PALI
Palisade Bio, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Palisade Bio (PALI) Stock: Buy, Sell, or Hold?
$1.15
+0.02 (+1.77%)
▲
5d:
-8.0%
30d:
-21.5%
90d:
-46.51%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
51/100
Position
OVERSOLD
30-Day Fair Range
$1.19 – $1.48
Position: OVERSOLD
Forward P/E & Valuation
-4.0x
Next 12M consensus est.
Wall Street Target
$9.80
+767.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.08 / $1.30
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: PALI shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When PALI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PALI is currently trading at $1.15, which is considered oversold relative to its 30-day fair value range of $1.19 to $1.48.
Technical Outlook: Technically, PALI is in a strong downtrend. Immediate support is located at $1.08, while resistance sits at $1.30.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.80 (+767.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PALI is in a strong downtrend. Immediate support is located at $1.08, while resistance sits at $1.30.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.80 (+767.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.19 -
$1.48
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.19 -
$1.48
Current vs Trading Range
OVERSOLD
Support Level
$1.08
Resistance Level
$1.30
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 767.3% below Wall St target ($9.80)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.98
Wall Street Target
$9.80
(+767.3%)
Share PALI Analysis
Share this live PALI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PALI)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Investor bullish on $PALI following presentation of new clinical, pharmacokinetic, pharmacodynamic, and mechanistic data supporting Phase 2 trial of PALI-2108 in ulcerative colitis and Crohn's disease at ACG 2026.
Key Retail Themes:
Positive clinical trial data
Advancement in Phase 2 trial of PALI-2108
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 10:00 AM ET
Data refreshes hourly during market hours. Next update: 11:00 AM
Data refreshes hourly during market hours. Next update: 11:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PALI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 52 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 42 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 46 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
18 analysts |
$72 | 31 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PALI Research Pages
